Work

TCT-596 Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights from the Serial IVUS analysis of the pivotal, prospective, multicentre, DESolve NX Trial